StonvexLoading…
StonvexStonvexStonvexCore line items from CRS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $2.88B | $2.76B | $2.55B | $1.84B |
Operating Income | $521.80M | $323.10M | $133.10M | $-24.90M |
Net Income | $376.00M | $186.50M | $56.40M | $-49.10M |
EPS (Diluted) | $7.42 | $3.70 | $1.14 | $-1.01 |
Total Assets | $3.49B | $3.29B | $3.05B | $2.93B |
Total Liabilities | $1.60B | $1.66B | $1.66B | $1.60B |
Cash & Equivalents | $315.50M | $199.10M | $44.50M | $154.20M |
Free Cash Flow OCF − CapEx | $286.10M | $178.30M | $-67.60M | $-85.30M |
Shares Outstanding | 49.71M | 49.78M | 48.64M | 48.29M |